IL-10 secretion of PBMC in IS-treated AChR-MG patients was also higher than that of IS-treated MuSK-MG patients (n: 11, p = 0.001) implicating that this difference is AChR-MG subgroup related. This evidence concerns the gene MUSK and myasthenia gravis.